225 related articles for article (PubMed ID: 22424082)
1. Genomics, personalized medicine and cancer practice.
Dancey J
Clin Biochem; 2012 Apr; 45(6):379-81. PubMed ID: 22424082
[No Abstract] [Full Text] [Related]
2. Personalized medicine in oncology: tailoring the right drug to the right patient.
Jiang Y; Wang M
Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
[TBL] [Abstract][Full Text] [Related]
3. Personalized-medicine trials on the rise.
Benowitz S
J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
[No Abstract] [Full Text] [Related]
4. The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
Arnedos M; Vielh P; Soria JC; Andre F
J Pathol; 2014 Jan; 232(2):274-82. PubMed ID: 24114621
[TBL] [Abstract][Full Text] [Related]
5. Personalized oncology: genomic screening in phase 1.
Tuxen IV; Jønson L; Santoni-Rugiu E; Hasselby JP; Nielsen FC; Lassen U
APMIS; 2014 Aug; 122(8):723-33. PubMed ID: 25046202
[TBL] [Abstract][Full Text] [Related]
6. Impact of genomics on personalized cancer medicine.
Arteaga CL; Baselga J
Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
[TBL] [Abstract][Full Text] [Related]
7. Refocusing the war on cancer: the critical role of personalized treatment.
Potti A; Schilsky RL; Nevins JR
Sci Transl Med; 2010 Apr; 2(28):28cm13. PubMed ID: 20410527
[TBL] [Abstract][Full Text] [Related]
8. Innovative biomarker development for personalized medicine in breast cancer care.
Zografos GC; Roukos DH
Biomark Med; 2011 Feb; 5(1):73-8. PubMed ID: 21319967
[No Abstract] [Full Text] [Related]
9. Cancer-related forecast biomarkers: a topic in focus of the Worldwide Innovative Network in Personalized Cancer Medicine (WIN).
Schmitt M; Lazar V
Bioanalysis; 2010 May; 2(5):851-3. PubMed ID: 21083216
[No Abstract] [Full Text] [Related]
10. The changing face of percutaneous image-guided biopsy: molecular profiling and genomic analysis in current practice.
Marshall D; Laberge JM; Firetag B; Miller T; Kerlan RK
J Vasc Interv Radiol; 2013 Aug; 24(8):1094-103. PubMed ID: 23806383
[TBL] [Abstract][Full Text] [Related]
11. Clinical cancer genomics: how soon is now?
Taylor BS; Ladanyi M
J Pathol; 2011 Jan; 223(2):318-26. PubMed ID: 21125684
[TBL] [Abstract][Full Text] [Related]
12. Epistatic interactions and drug response.
Weigelt B; Reis-Filho JS
J Pathol; 2014 Jan; 232(2):255-63. PubMed ID: 24105606
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing applications in cancer research.
Zhang W; Nykter M; Chen K
Cancer Lett; 2013 Nov; 340(2):149-50. PubMed ID: 23764479
[No Abstract] [Full Text] [Related]
14. International Cancer Conference: targeted therapies boom expected in 3-5 years.
Gethins M
J Natl Cancer Inst; 2011 Oct; 103(20):1491-3. PubMed ID: 21972228
[No Abstract] [Full Text] [Related]
15. Biology-driven phase II trials: what is the optimal model for molecular selection?
Andre F; Delaloge S; Soria JC
J Clin Oncol; 2011 Apr; 29(10):1236-8. PubMed ID: 21343554
[No Abstract] [Full Text] [Related]
16. [Molecular targeted cancer therapy and genetic tests --chairman's introductory remarks].
Hinoda Y
Rinsho Byori; 2012 Oct; 60(10):967-8. PubMed ID: 23323461
[TBL] [Abstract][Full Text] [Related]
17. [Personalized therapy].
Hallek M; Wolf J
Internist (Berl); 2013 Feb; 54(2):145-6. PubMed ID: 23371256
[No Abstract] [Full Text] [Related]
18. Ethical and legal aspects of oncogenomics.
Stankov K; Draskovic D; Mikov M
J BUON; 2012; 17(2):383-8. PubMed ID: 22740222
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapies of solid cancers: new options, new challenges.
Awada A; Aftimos PG
Curr Opin Oncol; 2013 May; 25(3):296-304. PubMed ID: 23493191
[TBL] [Abstract][Full Text] [Related]
20. Genomic medicine and targeted therapy for solid tumors.
Stevens EA; Rodriguez CP
J Surg Oncol; 2015 Jan; 111(1):38-42. PubMed ID: 25042935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
